BOTHELL, Wash., July 13 /PRNewswire-FirstCall/ -- Cardiac
Science Corporation (Nasdaq: CSCX), a global leader in
automated external defibrillator (AED) and diagnostic cardiac
monitoring devices, today expands its ECG and cardiac stress
product lines with CareCenter MD, a multimodality PC-based
diagnostic workstation designed for today's physician
practices.
(Logo:
http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO)
(Logo:
http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)
"CareCenter MD delivers superior ease-of-use and efficiency,"
said Rene Mitchell, Cardiac Science
director of marketing. "It's the first PC-based diagnostic
workstation that supports both resting ECG and stress testing with
a wireless data acquisition module. And, it allows physicians to
comply with pending electronic record mandates even if they have
not yet chosen an electronic medical record (EMR) partner."
The CareCenter MD diagnostic workstation features:
- Wireless data acquisition: A Bluetooth connection
between the patient and the diagnostic workstation removes the need
for cables, providing the opportunity for physicians to perform
testing in a wider range of settings.
- Advanced connectivity: Physicians can read, analyze, and
confirm patient tests from anywhere with a secure internet
connection. While no EMR is required to view data with CareCenter
MD, records can be easily transferred to an EMR if desired.
- Shared patient database: Data for both ECG and stress
tests are stored in the same database and can be easily accessed
and reviewed, allowing physicians to make real-time comparisons of
historical versus current patient data.
- Modern user interface: A simple and intuitive interface
featuring one-button navigation makes CareCenter MD easy-to-use,
reducing the need for training and allowing fast and efficient
workflow.
"This is another important new product for our cardiac
monitoring business," said Dave Marver, Cardiac Science president
and chief executive officer. "We are extending our leadership in
primary care cardiology in 2010 with a series of technology
introductions."
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of
advanced diagnostic and therapeutic cardiology devices and systems,
including automated external defibrillators (AED),
electrocardiograph devices (ECG/EKG), cardiac stress treadmill and
systems, PC-based diagnostic workstations, Holter monitoring
systems, hospital defibrillators, vital signs monitors, cardiac
rehabilitation telemetry systems, and cardiology data management
systems (informatics) that connect with hospital information (HIS),
electronic medical record (EMR), and other information systems. The
company sells a variety of related products and consumables and
provides a portfolio of training, maintenance, and support
services. Cardiac Science, the successor to the cardiac businesses
that established the trusted Burdick®, HeartCentrix®, Powerheart®,
and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost
100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or
visit http://www.cardiacscience.com.
For updates and information on worldwide defibrillation and
cardiac monitoring, find us on the Cardiac Science blog at
http://www.cardiacscience.com/blog, Twitter at
http://twitter.com/cardiacscience, Facebook at
http://budurl.com/CSonFB, and YouTube at
http://budurl.com/CSonYT.
Forward-Looking Statements
This press release contains forward-looking statements. The word
"believe," "expect," "intend," "anticipate," variations of such
words, and similar expressions identify forward-looking statements,
but their absence does not mean that the statement is not
forward-looking. Forward looking statements in this press release
include, but are not limited to, those that refer to product
compliance with legal mandates, regulations or other applicable
legal authority; the relative importance of one or more particular
products to Cardiac Science's business or any portion of its
business; and the anticipated future introduction of new
technologies and products. These are forward-looking
statements for purposes of the safe harbor provisions under the
Private Securities Litigation Reform Act of 1995. Actual results
and performance may vary significantly from those expressed or
implied in such statements. Factors that could cause or contribute
to such varying results and other risks include those more fully
described in the Annual Report on Form 10-K filed by Cardiac
Science Corporation for the year ended December 31, 2009, as updated by subsequent
quarterly reports on Form 10-Q. Cardiac Science Corporation
undertakes no duty or obligation to update the information provided
herein.
For more information,
|
|
Company Contact:
|
Investor Contact:
|
Media Contact:
|
|
Mike Matysik
Cardiac Science
Corporation
Senior Vice President and
CFO
425.402.2009
|
Matt Clawson
Allen & Caron
949.474.4300
matt@allencaron.com
|
Christopher Gale
EVC Group Inc.
646.201.5431
203.570.4681
cgale@evcgroup.com
|
|
|
|
|
|
|
LOGO: http://www.cardiacscience.com/images/main_logo.gif
CSCX-G
SOURCE Cardiac Science Corporation